Specific immune response in adult medical personnel immunized with acellular pertussis vaccine with special emphasis on T helper cell response

Vaccine

Volumn 15, Issue 17-18, 1997, Pages 1917-1921

  Lin, Tzou Yien ^a   Chiang, Bor Luen ^b  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acellular pertussis vaccine; Cytokine; Filamentous hemagglutinin; Pertussis toxin

Indexed keywords

CYTOKINE; HEMAGGLUTININ; PERTUSSIS VACCINE;

ADULT; ANOREXIA NERVOSA; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEVER; HELPER CELL; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INJECTION PAIN; IRRITABILITY; MEDICAL PERSONNEL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; VOLUNTEER;

ADHESINS, BACTERIAL; ADULT; AGING; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; CYTOKINES; HEALTH PERSONNEL; HEMAGGLUTININS; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PERTUSSIS VACCINE; PHENOTYPE; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 0030834809     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00127-8     Document Type: Article

References (36)

1. Cherry, J.D., Brunell, P.A., Golden, G.S. and Karzon, D.T. Report of the task force on pertussis and pertussis immunization. Pediatrics 1988, 81, S939-984.
2. Cherry, J.D., Baraff, L.J. and Hewlett, E. The past, present and future of pertussis. The role of adults in epidemiology and future control. Western Journal of Medicine 1989, 150, 319-328.
3. Linnemann, C.C. Jr. and Nasenbeny, J. Pertussis in the adult. Annual Review of Medicine 1977, 28, 179-185.
4. Herwaldlt, L.A. Pertussis in adults. Archives of International Medicine 1991, 115, 1510-1512.
5. Nelson, J.D. The changing epidemiology of pertussis in young infants: The role of adults as reservoir of infection. AJDC 1978, 132, 371-373.
6. Mink, C.M., Cherry, J.D. and Christenson, P. A search for B. pertussis in infection in college students. Clinical Infectious Diseases 1992, 14, 467-471.
7. Linnemann, C.C. Jr., Ramundo, N. and Perlstein, P.H. et al. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975, 2, 540-543.
8. Aoyama, T., Takeuchi, Y., Goto, A., Iwai, H., Murase, Y. and Iwata, T. Pertussis in adults. AJDC 1992, 146, 163-166.
9. Trollfors, B. and Rabo, E. Whooping cough in adults. British Medical Journal 1981, 283, 696-697.
10. Bass, J.W. and Stephenson, S.R. The return of pertussis. Pediatric Infectious Diseases Journal 1987, 6, 141-144.
11. Nabel, G.R., Bernier, R.H. and Esber, E.C. et al. Acellular and whole cell pertussis vaccine in Japan: Report of visit by US scientist. JAMA 1987, 257, 1351-1356.
12. Kimura, M. and Kumo-Sakai, H. Developments in pertussis immunization in Japan. Lancet 1990, 336, 30-32.
13. Kimura, M. and Kuno-Sakai, H. Current epidemiology of pertussis in Japan. Pediatric Infectious Diseases 1990, 9, 705-709.
14. Huang, L.M., Lee, C.Y., Lin, T.Y., Chen, J.M., Lee, P.I. and Hsu, C.Y. Responses to primary and a booster dose of acellular, component, and whole cell pertussis vaccines initiated at 2 months of age. Vaccine 1996, 14, 912-922.
15. Greco, D., Salmasos, S. and Mastrantonio, P. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. New England Journal of Medicine 1996, 334, 341-348.
16. Gustafsson, L., Hallander, H.O., Olin, P., Reizenstein, E. and Storsaeter, J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. New England Journal of Medicine 1996, 334, 349-355.
17. Rutter, D.A., Ashworth, L.A.E. and Day, A. et al. Trials of a new acellular pertussis vaccine in healthy adult volunteers. Vaccine 1988, 6, 29-32.
18. Ruuskaneno, N.A. and Putto-Laurila, A. et al. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine 1991, 9, 117-121.
19. Edwards, K.M., Decker, M.D. and Grahm, B.S. et al. Adult immunization with acellular pertussis vaccine. JAMA 1993, 269, 53-56.
20. Petersen, J.W., Ibsen, P.H. and Haslov, K. et al. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobronchial lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infection and Immunity 1992, 60, 4653-4670.
21. Ng, V.L., York, M. and Hadley, W.K. Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome. Journal of Clinical Microbiology 1989, 27, 337-338.
22. Doebbeling, B.N., Feilmeier, M.L. and Herwaldt, L.A. Pertussis in an adult male infected with the human immunodeficiency virus. Journal of Infectious Diseases 1990, 61, 1296-1298.
23. Bromberg, K., Tannis, G. and Steiner, P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infection and Immunity 1991, 59, 4715-4719.
24. Mills, K.H.G., Barnard, A., Watkins, and Redhead, K. Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infection and Immunity 1993, 61, 399-410.
25. Redhead, K., Watkins, J., Barnard, A. and Mills, K.H.G. Effective immunization against Bordetella pertussis respiratory tract infection in mice is dependent on induction of cell-mediated immunity. Infection and Immunity 1993, 61, 3190-3198.
26. Wierty, E.J.H., Loggen, H.G., Wanoort, H.C. and Kreeftenberg, J.G. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous hemagglutinin in humans. Journal of Biological Standardization 1989, 17, 181-190.
27. Podda, A., Nencioni, L. and De Magistris, M.T. et al. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. Journal of Experimental Medicine 1990, 172, 861-868.
28. Tomoda, T., Ogura, H. and Kurashige, T. Immune responses to Bordetella pertussis infection and vaccination. Journal of Infectious Diseases 1991, 163, 559-563.
29. Petersen, J.W., Ibsen, P.H., Bentzon, M.W., Capiau, C. and Heron, I. The cell mediated and humoral immune responses to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiology and Immunology 1991, 76, 279-288.
30. Chiang, B.L., Chou, C.C., Ding, H.J., Huang, M.S., Chen, J.M. and Hsieh, K.H. Establishment of human IgE system in severe combined immunodeficient mice with peripheral blood mononuclear cells from asthmatic children. Journal of Allergy and Clinical Immunology 1995, 95, 69-76.
31. Storsaeter, J., Blackwelder, W.C. and Hallander, H.O. Pertussis antibodies, protection, and vaccine efficacy after household exposure. AJDC 1992, 146, 167-172.
32. Kong, A.S. and Morse, S.I. The in vivo effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. 1. Proliferative response. Journal of Experimental Medicine 1977, 145, 151-162.
33. deMagistris, T.M., Romano, M., Nuti, S., Rappuoli, R. and Tagliabue, A. Dissecting human T cell responses against Bordetella species. Journal of Experimental Medicine 1988, 168, 1351-1362.
34. Odelram, H., Granstrom, M., Hedenskog, S., Duchen, K. and Bjorksten, B. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminum content of the vaccines. Pediatric Allergy and Immunology 1994, 5, 118-123.
35. Vogel, F.R., Leclerc, C. and Schutze, M.P. et al. Modulation of carrier induced epitopic suppression by Bordetella pertussis components and muramyl peptide. Cell Immunology 1987, 107, 40-51.
36. Francoise, M.A. and Luc, D.L. Adjuvants: current status, clinical perspectives and future prospects. Immunology Today 1993, 6, 281-284.